Position in TMO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,012,551,800
-$123,170,200 QoQ
Shares Held
2,060,000
+5.1% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
8.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Unisphere Establishment holds $1,133,706,200 across 2 Diagnostics & Research names. TMO ranks #1 (89.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,060,000 | $1,012,551,800 | |
| 2 | DHR |
Danaher Corp /De/
|
639,000 | $121,154,400 |
All Filings in TMO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,012,551,800 | 2,060,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,135,722,000 | 1,960,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $999,141,200 | 2,060,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $835,247,600 | 2,060,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $970,320,000 | 1,950,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $884,391,000 | 1,700,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $989,712,000 | 1,600,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $829,500,000 | 1,500,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $813,694,000 | 1,400,000 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $716,566,500 | 1,350,000 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||